Esteve,Codina A.; Niederstätter,H.; Parson,W.;

The amelogenin test integrated in most commercial polymerase chain reaction (PCR) multiplex kits is routinely used in the forensic field for gender determination of DNA samples. It has been demonstrated that this test is not entirely reliable. Males with deletions in the homologous amelogenin part on the Y chromosome (AMELY) were erroneously typed as females due to lack of Y-specific amelogenin amplification. Also, primer binding site mutations that result in a failure to amplify the AMELY or the X-chromosomal part (AMELX) have been observed. For clarification of such phenomena, a new PCR multiplex (GenderPlex) is presented, co-amplifying two different regions of the amelogenin gene (55/58 and 106/112 bp for the AMELX and AMELY alleles, respectively), a 93-bp sequence stretch of the SRY gene and four mini-X-STR loci DXS7424, DXS8378, DXS6803 and GATA172D05 (maximum product size less than 140 bp). This strategy helps with the evaluation of samples for the presence of amelogenin-based primer site mutations and confirms a male genotype by the absence of heterozygote X-STR alleles and the presence of an SRY-related peak. The short amplicon sizes of all involved loci proved to be beneficial in a study on artificially degraded DNA. Furthermore, we demonstrate by means of sensitivity, human specificity and mixture studies that the multiplex is suitable for investigations in the forensic scene. Finally, the performance of the GenderPlex was evaluated on a west Eurasian population sample from Austria comprising 166 male and 104 female individuals

Int J Legal Med 2009 123(6):459-464
PubMed: 19089439